The remote effects of intravitreal anti-VEGF therapy.

F Balta, M Merticariu, C Taban, G Neculau, A Merticariu, D Muresanu, D Badescu, V Jinga

Abstract readClinical Trial

In one paragraph

Trial report in Journal of medicine and life. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

F BaltaDepartment of Vitreo-Retinal Surgery, Emergency Eye Hospital and Clinic, Bucharest, Romania.

M MerticariuDepartment of Urology, "Theodor Burghele" Clinical Hospital, Bucharest, Romania.

C TabanDepartment of Vitreo-Retinal Surgery, Emergency Eye Hospital and Clinic, Bucharest, Romania.

G NeculauRomanian Centre for Economic Modeling.

A MerticariuDepartment of Vitreo-Retinal Surgery, Emergency Eye Hospital and Clinic, Bucharest, Romania.

D MuresanuRoNeuro" Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania, ; Department of Clinical Neurosciences, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

D BadescuDepartment of Urology, "Theodor Burghele" Clinical Hospital, Bucharest, Romania.

V JingaDepartment of Urology, "Theodor Burghele" Clinical Hospital, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedBevacizumabHumansIntravitreal InjectionsMacular DegenerationMaleMiddle AgedProspective StudiesProstatic HyperplasiaQuality of LifeTreatment OutcomeUrinary RetentionVascular Endothelial Growth Factor ABevacizumabVascular Endothelial Growth Factor AAvastinbenign prostatic hyperplasiaintravitreal

Identifiers

PMID27928444

PMCPMC5141400

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.